Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,450.00 at Morgan Stanley

Mettler-Toledo International (NYSE:MTDGet Free Report) had its price objective raised by Morgan Stanley from $1,275.00 to $1,450.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the medical instruments supplier’s stock. Morgan Stanley’s target price would suggest a potential upside of 0.22% from the company’s previous close.

Several other equities research analysts have also recently weighed in on MTD. Wells Fargo & Company boosted their price target on shares of Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Monday. Stifel Nicolaus upped their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Monday. Barclays upped their price target on shares of Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the stock an “overweight” rating in a report on Monday. Citigroup dropped their price objective on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Finally, Wolfe Research began coverage on shares of Mettler-Toledo International in a report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $1,461.27.

View Our Latest Research Report on Mettler-Toledo International

Mettler-Toledo International Trading Up 2.2%

Shares of Mettler-Toledo International stock opened at $1,446.84 on Tuesday. The company has a fifty day moving average of $1,244.14 and a 200 day moving average of $1,274.25. Mettler-Toledo International has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17. The company has a market capitalization of $29.24 billion, a P/E ratio of 32.56, a P/E/G ratio of 2.92 and a beta of 1.23. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12.

Mettler-Toledo International (NYSE:MTDGet Free Report) last released its quarterly earnings data on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.78 by $0.68. The firm had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter last year, the business posted $10.09 earnings per share. On average, sell-side analysts anticipate that Mettler-Toledo International will post 47.25 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Mettler-Toledo International

A number of large investors have recently made changes to their positions in MTD. Capital International Investors lifted its holdings in shares of Mettler-Toledo International by 12.7% during the 4th quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock valued at $1,351,064,000 after purchasing an additional 109,508 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its position in shares of Mettler-Toledo International by 0.5% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock worth $964,174,000 after purchasing an additional 3,157 shares in the last quarter. Geode Capital Management LLC grew its stake in Mettler-Toledo International by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock worth $830,879,000 after buying an additional 14,106 shares during the last quarter. Norges Bank acquired a new position in Mettler-Toledo International during the 4th quarter valued at about $520,989,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Mettler-Toledo International by 0.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 272,829 shares of the medical instruments supplier’s stock valued at $380,375,000 after buying an additional 1,052 shares during the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Mettler-Toledo International

Here are the key news stories impacting Mettler-Toledo International this week:

  • Positive Sentiment: Mettler-Toledo reported second-quarter earnings of $11.46 per share, exceeding the $10.78 analyst consensus. Revenue reached approximately $1.03 billion and increased 4.5% year over year, helped by strong sales in China and emerging markets. Management also raised its 2026 sales and earnings outlook, providing a favorable catalyst for investors. MTD Second Quarter Earnings Beat Estimates on China-Led Sales Growth
  • Positive Sentiment: Stifel Nicolaus raised its price target from $1,400 to $1,600 and maintained a “buy” rating, implying additional upside from the stock’s referenced price. Stifel Raises Mettler-Toledo Price Target
  • Positive Sentiment: Barclays increased its target from $1,300 to $1,575 and retained an “overweight” rating, reflecting greater confidence in MTD’s earnings trajectory. Barclays Raises Mettler-Toledo Price Target
  • Positive Sentiment: Mettler-Toledo appointed Natalia Shuman to its board. Her experience as CEO of MISTRAS Group adds industrial technology and asset-integrity expertise, although the governance change is unlikely to materially affect near-term earnings. Natalia Shuman Joins Mettler-Toledo Board of Directors
  • Neutral Sentiment: Wells Fargo raised its price target from $1,225 to $1,450 but kept an “equal weight” rating, suggesting the firm sees limited near-term upside after MTD’s strong advance. Wells Fargo Raises Mettler-Toledo Price Target

Mettler-Toledo International Company Profile

(Get Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

See Also

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.